Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
Full name: Eli Lilly Y Cia De Mexico S.A. de C.V.
Legal Form: Limited Liability Company
Operational Status: Operational
Incorporation Date: 21-Sep-43
Pharmaceutical and veterinarian medicines.
Eli Lilly Mexico S.A. de C.V., a subsidiary of Eli Lilly & Company, is a company dedicated to the pharmaceutical industry research and development of solutions for human health care in therapeutic areas including oncology and critical care, neurosciences, cardiology, endocrinology, diabetes, infectious disease and erectile dysfunction as well as in animal health areas. The company began operations in Mexico in 1943.More
|Company Tear Sheet|
|NAICS Industry Classification||✓||✕|
|Share Price information||✓||✕|
|Subsidiaries and Affiliates||✓||✕|
|Key Financial Highlights||✓||✕|
|Financial Performance Charts||✓||✕|
|Latest M&A and ECM Deals||✓||✕|
|EMIS Credit Analytics|
|EMIS Benchmark Score||✓||✕|
- or -
EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.
If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.